Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorStanford University

About this trial

Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Over 18

Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer

Disqualifiers

Under 18

No family or personal history of gastric or esophageal cancer

Trial population

Adults with gastric or esophageal cancer

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Blood draw

    Procedure/Surgery
  • Tissue tumor biopsy

    Procedure/Surgery

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

p53 activity by routine pathologic analysis

Time frame
time of collection
2

NER activity by routine pathologic analysis

Time frame
time of collection

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Stanford University

Lead sponsor

National Institutes of Health (NIH)

Collaborator